Meeting NewsVideo

VIDEO: A deep dive into CV benefits of prescription fish oil

CHICAGO — In this video exclusive, Deepak L. Bhatt, MD, MPH, highlights results of the REDUCE-IT trial, which found that icosapent ethyl was superior to placebo for reducing risk for ischemic events.

The data show “good safety, tolerability and very robust efficacy,” according to Bhatt, who is executive director of interventional cardiovascular programs at Brigham and Women’s Heart & Vascular Center, professor of medicine at Harvard Medical School and chief medical editor of Cardiology Today’s Intervention.

Watch the video for more.

CHICAGO — In this video exclusive, Deepak L. Bhatt, MD, MPH, highlights results of the REDUCE-IT trial, which found that icosapent ethyl was superior to placebo for reducing risk for ischemic events.

The data show “good safety, tolerability and very robust efficacy,” according to Bhatt, who is executive director of interventional cardiovascular programs at Brigham and Women’s Heart & Vascular Center, professor of medicine at Harvard Medical School and chief medical editor of Cardiology Today’s Intervention.

Watch the video for more.

    See more from American Heart Association Scientific Sessions